UCSB strives to spur more manufacturing
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →5 tri-county companies among Deloitte Fast 500
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →European regulators approve Amgen cancer drug Kyprolis
Thousand Oaks-based Amgen scored another major victory Nov. 19. European regulators approved experimental drug Kyprolis on Thursday for patients who have received at least one prior treatment for multiple-myeloma. Kyprolis was the cornerstone of Amgen’s $10.4 billion buyout of Onyx Pharmaceuticals in 2013. Multiple-myeloma is a form of blood cancer that forms in plasma cells Read More →
Read More →Semtech’s LoRa technology debuts in Ventura County, around the world
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Dubroff: UCSB grad school will help tech managers innovate in digital age
The Central Coast has a growing reputation as a cool place for startups. But amid dozens of new ventures and talk of a tech-centric future looms the reality of growing a fully functional technology company. Listening to the earnings calls for AppFolio and MindBody, which recently had successful IPOs, you begin to realize just how Read More →
Read More →AppFolio reports strong revenue for third quarter
AppFolio founder and chief strategist Klaus Schauser Santa Barbara-based cloud computing firm AppFolio said revenue jumped 56 percent to $20.3 million for the third quarter as losses grew to $4.8 million. The company, which specializes in providing business-to-business cloud services, said that it had increased both law firm and property management Read More →
Read More →Port Hueneme’s Stellar Biotechnologies trading on Nasdaq
Port Hueneme-based Stellar Biotechnologies started trading on the Nasdaq stock exchange Nov. 5. Stellar makes a protein for immunotherapy treatments using a unique sea snail only found off the coastal shores of a small part of California. Shares opened at $8.74 on Nov. 5 and were trading on the Nasdaq at $9.40 as of 11:30 Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
